Relationship between proteolytically cleaved gelsolin and levels of amyloid-β protein in the brains of down syndrome subjects

Journal of Alzheimer's Disease

Volumn 22, Issue 2, 2010, Pages 609-617

  Ji, Lina ^a   Chauhan, Ved ^a   Mehta, Pankaj ^a   Wegiel, Jerzy ^a   Mehta, Sangita ^a   Chauhan, Abha ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; amyloid protein; apoptosis; carboxyl terminal fragment of gelsolin; Down syndrome

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; GELSOLIN; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BRAIN; CARBOXY TERMINAL SEQUENCE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; SCHOOL CHILD;

EID: 78650817812     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-101029     Document Type: Article

References (47)

1. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249.
2. Hyman BT (1992) Down syndrome and Alzheimer disease. Prog Clin Biol Res 379, 123-142.
3. GlennerGG (1983) Alzheimer's disease. The commonest form of amyloidosis. Arch Pathol Lab Med 107, 281-282.
4. Matsuoka Y, Andrews HF, Becker AG, Gray AJ, Mehta PD, Sano MC, Dalton AJ, Aisen PS (2009) The relationship of plasma Abeta levels to dementia in aging individuals with Down syndrome. Alzheimer Dis Assoc Disord 23, 315-318.
5. Schupf N, Patel B, Pang D, Zigman WB, Silverman W, Mehta PD, Mayeux R (2007) Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome. Arch Neurol 64, 1007-1013.
6. Schupf N, Patel B, Silverman W, Zigman WB, Zhong N, Tycko B, Mehta PD, Mayeux R (2001) Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome. Neurosci Lett 301, 199-203.
7. Chauhan VP, Ray I, Chauhan A, Wisniewski HM (1999) Binding of gelsolin, a secretory protein, to amyloid beta-protein. Biochem Biophys Res Commun 258, 241-246.
8. Chauhan V, Ji L, Chauhan A (2008) Anti-amyloidogenic, antioxidant and anti-apoptotic role of gelsolin in Alzheimer's disease. Biogerontology 9, 381-389.
9. Tanaka J, Sobue K (1994) Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 14, 1038-1052.
10. Yin HL, Kwiatkowski DJ, Mole JE, Cole FS (1984) Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 259, 5271-5276.
11. Wen D, Corina K, Chow EP, Miller S, Janmey PA, Pepinsky RB (1996) The plasma and cytoplasmic forms of human gel-solin differ in disulfide structure. Biochemistry 35, 9700-9709.
12. Hirko AC, Meyer EM, King MA, Hughes JA (2007) Peripheral transgene expression of plasma gelsolin reduces amyloid in transgenic mouse models of Alzheimer's disease. Mol Ther 15, 1623-1629.
13. Ji L, Chauhan A, Chauhan V (2008) Cytoplasmic gelsolin in pheochromocytoma-12 cells forms a complex with amyloid beta-protein. Neuroreport 19, 463-466.
14. Antequera D, Vargas T, Ugalde C, Spuch C, Molina JA, Ferrer I, Bermejo-Pareja F, Carro E (2009) Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease. Neurobiol Dis 36, 42-50.
15. Ray I, Chauhan A, Wegiel J, Chauhan VP (2000) Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils. Brain Res 853, 344-351.
16. Matsuoka Y, Saito M, LaFrancois J, Saito M, Gaynor K, Olm V, Wang L, Casey E, Lu Y, Shiratori C, Lemere C, Duff K (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J Neurosci 23, 29-33.
17. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817827.
18. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, Danni O (2003) Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 35, 45-58.
19. Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90, 26282632.
20. Su JH, Zhao M, Anderson AJ, Srinivasan A, Cotman CW, 2001, Activated caspase-3 expression in Alzheimer's and aged control brain: correlation with Alzheimer pathology, Brain Res, 898, 350-357
21. LeBlanc A., Liu H., Goodyer C., Bergeron C., Hammond J., 1999, Caspase-6 role in apoptosis ofhuman neurons, amyloidogene-sis, and Alzheimer's disease, J Biol Chem, 274, 23426-23436
22. Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 11, 341-354.
23. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT (1997) Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278, 294-298.
24. Ji L, Chauhan A, Wegiel J, Essa MM, Chauhan V (2009) Gelsolin is proteolytically cleaved in the brains of individuals with Alzheimer's disease. J Alzheimers Dis 18, 105-111.
25. Ji L., Chauhan A., Muthaiyah B., Wegiel J., Chauhan V., 2009, Gelsolin levels are increased in the brain as a function of age during normal development in children that are further increased in Down syndrome, Alzheimer Dis Assoc Disord, 23, 319-322
26. Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T (2009) Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer's disease-related pathology. J Neurosci 29, 1846-1854.
27. Mehta PD, Capone G, Jewell A, Freedland RL (2007) Increased amyloid beta protein levels in children and adolescents with Down syndrome. J Neurol Sci 254, 22-27.
28. De Corte V, Demol H, Goethals M, Van Damme J, Gettemans J, Vandekerckhove J (1999) Identification of Tyr438 as the major in vitro c-Src phosphorylation site in human gelsolin: a mass spectrometric approach. Protein Sci 8, 234-241.
29. De Corte V, Gettemans J, Vandekerckhove J (1997) Phosphatidylinositol 4,5-bisphosphate specifically stimulates PP60(c-src) catalyzed phosphorylation ofgelsolin and related actin-binding proteins. FEBSLett 401, 191-196.
30. Paavilainen VO, Bertling E, Falck S, Lappalainen P (2004) Regulation of cytoskeletal dynamics by actin-monomer-binding proteins. Trends Cell Biol 14, 386-394.
31. Krucker T, Siggins GR, Halpain S (2000) Dynamic actin filaments are required for stable long-term potentiation (LTP) in area CA1 of the hippocampus. Proc Natl Acad Sci U S A 97, 6856-6861.
32. Allison DW, Gelfand VI, Spector I, Craig AM (1998) Role of actin in anchoring postsynaptic receptors in cultured hip-pocampal neurons: differential attachment of NMDA versus AMPA receptors. J Neurosci 18, 2423-2436.
33. Bryan J (1988) Gelsolin has three actin-binding sites. J Cell Biol 106, 1553-1562.
34. Hellweg T, Hinssen H, Eimer W (1993) The Ca(2+)-induced conformational change of gelsolin is located in the carboxyl-terminal half of the molecule. Biophys J 65, 799-805.
35. Sun H, Lin K, Yin HL (1997) Gelsolin modulates phospholi-pase C activity in vivo through phospholipid binding. J Cell Biol 138, 811-820.
36. Steed PM, Nagar S, Wennogle LP (1996) Phospholipase D regulation by a physical interaction with the actin-binding protein gelsolin. Biochemistry 35, 5229-5237.
37. Wang Q., Xie Y., Du QS., Wu XJ., Feng X., Mei L., McDonald JM., Xiong WC , 2003, Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin, J Cell Biol, 160, 565-575
38. Liu K, Solano I, Mann D, Lemere C, Mercken M, Trojanowski JQ, Lee VM (2006) Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease. Acta Neuropathol 112, 163-174.
39. Engidawork E, Gulesserian T, Seidl R, Cairns N, Lubec G (2001) Expression of a poptosis related proteins: RAIDD, ZIP kinase, Bim/BOD, p21, Bax, Bcl-2 and NF-kappaB in brains of patients with Down syndrome. J Neural Transm Suppl 61, 181-192.
40. Gulesserian T, Engidawork E, Yoo BC, Cairns N, Lubec G (2001) Alteration of caspases and other apoptosis regulatory proteins in Down syndrome. J Neural Transm Suppl 61, 163179.
41. Anderson AJ, Stoltzner S, Lai F, Su J, Nixon RA (2000) Morphological and biochemical assessment of DNA damage and apoptosis in Down syndrome and Alzheimer disease, and effect of postmortem tissue archival on TUNEL. Neurobiol Aging 21, 511-524.
42. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocam-pal long-term potentiation in vivo. Nature 416, 535-539.
43. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356.
44. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19, 8876-8884.
45. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogen-esis. Science 300, 486-489.
46. Wolf BB, Goldstein JC, Stennicke HR, Beere H, Amarante-Mendes GP, Salvesen GS, Green DR (1999) Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 94, 1683-1692.
47. Wadhawan V, Karim ZA, Mukhopadhyay S, Gupta R, Dikshit M, Dash D (2004) Platelet storage under in vitro condition is associated with calcium-dependent apoptosis-like lesions and novel reorganization in platelet cytoskeleton. Arch Biochem Biophys 422, 183-190.